Agenus Inc. Stock News

AGEN earnings call for the period ending March 31, 2022.

Agenus Inc. (NASDAQ:AGEN ) Q1 2022 Earnings Conference Call May 9, 2022 8:30 AM ET Company Participants Christine Klaskin - Vice President of Finance, Principal Financial Officer & Principal Accountin

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Pfizer Acquires Biohaven For $11B Pfizer Inc (NYSE: PFE) will acquire Biohaven Pharmaceutical Hold

Agenus (AGEN) delivered earnings and revenue surprises of 34.48% and 49.50%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Agenus (AGEN) delivered earnings and revenue surprises of 34.48% and 49.50%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Conference Call on Tuesday, May 10, 2022 at 8:30 a.m. ET Conference Call on Tuesday, May 10, 2022 at 8:30 a.m. ET

Regeneron's buyout of Checkpoint Pharmaceuticals is sparking a rally among clinical-stage cancer research companies today.

Regeneron's buyout of Checkpoint Pharmaceuticals is sparking a rally among clinical-stage cancer research companies today.

LEXINGTON, Mass., April 08, 2022 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq: AGEN), an immuno-oncology company with an extensive pipeline of therapeutics designed to activate immune response to cancers

LEXINGTON, Mass., April 05, 2022 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of therapeutics designed to activate immune response to cancers

Agenus (AGEN) and Targovax ASA signed a clinical collaboration and supply agreement to combine Targovax’s TG mutant KRAS cancer vaccines with Agenus'' QS-21 STIMULON adjuvant technology

LEXINGTON, Mass., March 07, 2022 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, adjuvants, and vaccines designed to activa

Gainers ECMOHO Limited (NASDAQ: MOHO ) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP ) shares jumped 39.2% to close at $2.06 after dipping 37% on Tuesday. Nordstrom, Inc. (NYSE: JWN ) shares jumped 37.8% to settle at $26.93 after the company reported better-than-expected Q4 EPS and sales results. The company also issued FY22 guidance. Regulus Therapeutics Inc. (NASDAQ: RGLS ) gained 35.6% to close at $0.3050. Indonesia Energy Corporation Limited (NASDAQ: INDO ) surged 34.5% to close at $14.50. Trevi Therapeutics, Inc. (NASDAQ: TRVI ) gained 32% to settle at $1.15. Arlo Technologies, Inc. (NYSE: ARLO ) rose 28.9% to close at $11.19 after the company reported better-than-expected Q4 results. The company also issued Q1 sales guidance above analyst estimates. Rocky Brands, Inc. (NASDAQ: RCKY ) climbed 26.6% to close at $47.47 following better-than-expected Q4 results. China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC ) gained 26.1% to close at $0.2181.

An optimistic analyst upgrade is powering the biotech's shares higher today.

An optimistic analyst upgrade is powering the biotech's shares higher today.